Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience
Vineel Bhatlapenumarthi, Anannya Patwari, Antoine Harb
Topics & Concepts
MedicineAtezolizumabDurvalumabNivolumabAdverse effectPembrolizumabInternal medicineImmunosuppressionCancerGenitourinary systemLung cancerTolerabilityImmunotherapyCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesAutoimmune Neurological Disorders and Treatments